ineresting : Of the outstanding shares, approximately one billion is in the 'float,' the balance is owned by insiders and long-term shareholders. "There have numerous questions concerning the status of our current FDA filing. To our best belief, our hopeful expectation is for a response around the end of September. However, our FDA advisors and consultants have indicated the FDA is running about 30 days behind schedule." Lifeline has tentative funding commitments under terms that will be less dilutive than in prior fundings.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.